# Naproxen Sodium and Diphenhydramine HCL

NDC: 11673-819
Generic name: Naproxen Sodium and Diphenhydramine HCL
Labeler / Manufacturer: TARGET CORPORATION
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240301

FDA application: ANDA213663

## Active ingredients

- DIPHENHYDRAMINE HYDROCHLORIDE: 25 mg/1
- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"11673-819"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=11673-819
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe82699d-fdc2-038e-e053-6294a90a606c